Novartis Investigative Site — Andalusia, Alabama

Novartis Investigative Site is a clinical research site located in Andalusia, Alabama, United States 36420.

Crixeo Clinical Trials Trust Score: 17/100 (FAILING). This profile has not yet been claimed by the site owner.

Novartis Investigative Site has participated in 7 clinical trials.

Therapeutic areas: Asthma, Cardiovascular Disease and Lipoprotein(a), Pulmonary Disease, Chronic Obstructive.

Sponsors: Novartis Pharmaceuticals.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Andalusia

Browse all research sites in Alabama · View every site in Andalusia

• SEC Clinical Research
• Research Site
• Andalusia
• GSK Investigational Site
• SEC Lung
• Pearl Investigative Site
• Investigational Research Center Site #1017
• Novo Nordisk Investigational Site
• 1237.19.10039 Boehringer Ingelheim Investigational Site
• Teva Investigational Site 14682
• Glenmark Investigational Site 23

Sponsor Feasibility Report

Trust Score: 17/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Novartis Investigative Site?

Novartis Investigative Site has a Crixeo Trust Score of 17/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Novartis Investigative Site conducted?

Novartis Investigative Site has 7 clinical trials on record. Their work covers Asthma, Cardiovascular Disease and Lipoprotein(a), Pulmonary Disease, Chronic Obstructive.

Is Novartis Investigative Site accredited by Crixeo Clinical Trials?

Novartis Investigative Site has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Novartis Investigative Site?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.